Mice Model Market Size to Reach USD 2 Billion by 2027 | Rise in Utilization of Mice Model in Production of Monoclonal Antibodies will Drive the Industry Growth, says Emergen Research
Increasing investments in research and development activities in pharmaceutical and biotechnology sectors and increasing use of mice model for personalized drug production are key factors driving mice model market growth.
Vancouver, British Columbia, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The global mice model market is projected to reach a market size of USD 2.00 Billion by 2027 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. A key factor driving high revenue growth of the market includes increasing utilization of mice models for personalized drug production. In addition, increasing investments in research and development initiatives and activities in pharmaceuticals and biotechnology sectors is another factor expected to augment global mice model market growth during the forecast period. Furthermore, rising use of mice models in the production of monoclonal antibodies is expected to support growth of the global mice model market to a significant extent during the forecast period.
However, a key factor that is expected to hamper market growth to some extent over the forecast period is continuous discovery of substitute approaches for animal studies.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/457
Key Highlights of Report
In February 2020, The Jackson Laboratory introduced the K18-hACE2 transgenic mouse to help in COVID-19 research activities with mice models.
During the forecast period, revenue from the knockout segment is expected to expand substantially. Use of knockout mice in study offers several benefits; for example, impact of the target gene can be minimized without any of the adverse effects of drugs and the genome can be modified to determine the essential role of several endogenous variables in behavior. This factor is expected to fuel revenue growth of this segment in the near future.
Revenue from the genetic testing segment is projected to expand at a sluggish CAGR of 6.9% over the forecast period. In genetic research and clinical studies of different human diseases, mice are often used as the mouse genome is highly similar to that of humans.
Due to the reliable execution of microinjection technology and subsequent high preference for this solution, revenue from the microinjection segment is expected to expand significantly throughout the forecast period.
The infectious diseases segment revenue is expected to expand substantially due to a variety of factors. Using mice models, groups of researchers can explore how pathogens initiate infections, determine the role of certain host genes in either disease prevention or mitigation, and identify potential targets for the control and diagnosis of a spectrum of contagious diseases. This has been resulting in high demand and use of the model for some decades.
The Asia Pacific market is expected to register highest revenue growth rate during the forecast period due to increasing growth of the biotechnology industry in developing economies in the region.
Key market participants include Envigo Ltd., TransViragen Inc., Charles River Laboratories International Inc., GenOway S.A., The Jackson Laboratory, Ozgene Pty Ltd., GVK Biosciences Private Limited, Taconic Biosciences Inc., Pharmaron, Inc., and Horizon Discovery Group plc.
Check Our Prices@ https://www.emergenresearch.com/select-license/457
Emergen Research has segmented the global mice model market on the basis of type, service, technology, application, end-use, and region.
Type Outlook (Revenue, USD Billion; 2017–2027)
Outbred
Hybrid
Inbred
Knockout
Spontaneous Mutant
Service Outlook (Revenue, USD Billion; 2017–2027)
Cryopreservation
Rederivation
Genetic Testing
Breeding
Quarantine
Others
Technology Outlook (Revenue, USD Billion; 2017–2027)
CRISPR
Nuclear Transfer
Embryonic Stem Cell Injection
Microinjection
Others
Application Outlook (Revenue, USD Billion; 2017–2027)
Cancer
Diabetes
Research & Development
Academics
Cardiovascular Studies
Genetic Studies
Infectious Diseases
Neurological Diseases
Others
End-use Outlook (Revenue, USD Billion; 2017–2027)
Pharmaceutical
Cosmetics
Biotechnology
Government
Contract Research Organizations
Academic & Research Institutes
Others
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/mice-model-market
Regional Outlook (Revenue, USD Billion; 2017–2027)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
BENELUX
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
Rest of MEA
Take a Look at our Related Reports:
In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027
Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027
Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-mice-model-market